| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 275.45M | 305.12M | 305.73M | 348.24M | 326.00M |
| Gross Profit | 40.62M | 185.17M | 167.79M | 53.80M | 56.67M |
| EBITDA | 58.05M | 64.53M | 61.35M | 72.47M | 70.80M |
| Net Income | 26.83M | 29.77M | 28.85M | 41.16M | 37.15M |
Balance Sheet | |||||
| Total Assets | 493.57M | 501.11M | 501.74M | 492.00M | 498.43M |
| Cash, Cash Equivalents and Short-Term Investments | 51.01M | 39.42M | 40.37M | 30.29M | 60.82M |
| Total Debt | 107.14M | 96.51M | 104.61M | 60.12M | 68.76M |
| Total Liabilities | 180.36M | 176.35M | 186.78M | 148.97M | 159.84M |
| Stockholders Equity | 313.21M | 324.76M | 314.89M | 342.97M | 338.69M |
Cash Flow | |||||
| Free Cash Flow | 40.45M | 37.96M | 27.18M | 20.60M | 19.47M |
| Operating Cash Flow | 64.00M | 53.04M | 48.72M | 39.88M | 42.79M |
| Investing Cash Flow | -20.41M | -15.01M | -21.06M | -20.05M | -23.10M |
| Financing Cash Flow | -35.51M | -38.53M | -17.77M | -51.27M | -37.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | €505.83M | 10.11 | 7.22% | 2.31% | 3.17% | 5.35% | |
67 Neutral | €572.90M | 21.76 | 8.59% | 3.80% | -9.73% | -9.62% | |
56 Neutral | €317.69M | 34.76 | 2.68% | ― | -8.69% | -5.22% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | €184.77M | 11.42 | 6.04% | 2.83% | -8.67% | -31.83% | |
42 Neutral | €100.34M | 70.28 | 0.35% | 7.08% | -3.55% | 3378.81% |